RE:RE:PIECE OF CR@P???ask yourself this: does $N currently do USD 23mil Q2 with 14mil ebidta, and show / project 30% growth qtr on qtr? does anyone have 90000+ reg patients other than TRUL and CGC? how about so many potential catalysts to make your head spin? like stores opening one after another? expanding Q3 earnings report? midterms? (current toss up: dem win in FL and its full on legalization rec just like CA / if gop win then status quo and alot easier for TRUL maintains monopoly... either way its good for TRUL's potential growth)? med flower sales? 3x projected growth of the FL med market in 2019, then double again in 2020? going multi-state ? how bout going international? current price levels are not reflecting these catalysts, and these effects will cumutively drive the SP up, parabolically when you factor in the low float well into 2019... IMHO